Literature DB >> 6448276

A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats.

S A Moore, R G Peterson, D L Felten, B L O'Connor.   

Abstract

Motor and sensory conduction velocities were measured in the sural and tibial nerves of streptozotocin (stz)-diabetic, alloxan-diabetic, and age-matched control rats. Conduction velocity (CV) determinations were made 2 weeks and 2, 4, 8, and 12 months following the induction of diabetes. CVs of control, stz-diabetic, and alloxan-diabetic rats were compared at each time period by one way analysis of variance and when appropriate by the Newman-Keuls multiple range test for multiple comparisons. Reductions of 10-20% in CV of diabetic rats were observed in several classes of sensory and motor nerve fibers. Larger reductions (31 and 38%) were seen in 2 classes of sensory nerve fibers in 12 month stz-diabetic rats. Sensory CV was slowed earlier and more frequently than motor CV. Differential involvement was also seen among the several classes of sensory nerve fibers examined. Slower conducting sensory fibers appeared to be affected earlier and more frequently than faster conducting sensory fibers. Comparing alloxan-diabetic with stz-diabetic rats revealed significant differences in CV 8 months after the induction of diabetes. Motor and sensory CVs of the tibial nerve were slower in stz-diabetic rats than in alloxan-diabetic rats. In general, the neuropathy appeared to be less severe and to develop later in the alloxan-diabetic rats. These data suggest that the neuropathy of stz- and alloxan-diabetes is primarily sensory in nature, and that the neuropathy in these 2 widely used models of diabetes may not be entirely equivalent.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448276     DOI: 10.1016/0022-510x(80)90156-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

Review 2.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Ca-controlled, reversible structural transition in myelin.

Authors:  A E Blaurock; J L Yale; B I Roots
Journal:  Neurochem Res       Date:  1986-08       Impact factor: 3.996

4.  The correlation between sensory nerve conduction velocities and three metabolic indices in rats treated with streptozotocin.

Authors:  P O Julu
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

Review 5.  Animal models of peripheral neuropathies.

Authors:  Ahmet Höke
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

6.  Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats.

Authors:  V Ralevic; A Belai; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 7.  Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Authors:  G J Biessels; V Bril; N A Calcutt; N E Cameron; M A Cotter; R Dobrowsky; E L Feldman; P Fernyhough; J Jakobsen; R A Malik; A P Mizisin; P J Oates; I G Obrosova; R Pop-Busui; J W Russell; A A Sima; M J Stevens; R E Schmidt; S Tesfaye; A Veves; A I Vinik; D E Wright; S Yagihashi; M A Yorek; D Ziegler; D W Zochodne
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

8.  Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Authors:  K R Gillon; J N Hawthorne; D R Tomlinson
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

9.  Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area.

Authors:  R Medori; L Autilio-Gambetti; S Monaco; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Altered metabolic incorporation of fucose and leucine into PNS myelin of 25-week-old diabetic (C57BL/Ks [db/db]) mice: effects of untreated diabetes on nerve metabolism.

Authors:  M G Chez; R G Peterson
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.